New hope for pancreatic cancer: drug combo shows promise in trial
Disease control
Completed
This study tested whether adding two experimental drugs (TTX-030 and budigalimab) to standard chemotherapy helps people with metastatic pancreatic cancer live longer without their cancer growing. 194 adults who had not received prior treatment for their advanced cancer took part.…
Phase: PHASE2 • Sponsor: Trishula Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 11:37 UTC